260 related articles for article (PubMed ID: 20547735)
1. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
Wang X; Sykes DB; Miller DS
Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
[TBL] [Abstract][Full Text] [Related]
2. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
3. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
4. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.
More VR; Campos CR; Evans RA; Oliver KD; Chan GN; Miller DS; Cannon RE
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1199-1212. PubMed ID: 27193034
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.
Wang X; Campos CR; Peart JC; Smith LK; Boni JL; Cannon RE; Miller DS
J Neurosci; 2014 Jun; 34(25):8585-93. PubMed ID: 24948812
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
8. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier.
Bauer B; Hartz AM; Lucking JR; Yang X; Pollack GM; Miller DS
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1222-34. PubMed ID: 18349876
[TBL] [Abstract][Full Text] [Related]
9. Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.
Sugiyama D; Kusuhara H; Lee YJ; Sugiyama Y
Pharm Res; 2003 Sep; 20(9):1394-400. PubMed ID: 14567633
[TBL] [Abstract][Full Text] [Related]
10. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
Hartz AM; Madole EK; Miller DS; Bauer B
J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386
[TBL] [Abstract][Full Text] [Related]
12. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.
Kast HR; Goodwin B; Tarr PT; Jones SA; Anisfeld AM; Stoltz CM; Tontonoz P; Kliewer S; Willson TM; Edwards PA
J Biol Chem; 2002 Jan; 277(4):2908-15. PubMed ID: 11706036
[TBL] [Abstract][Full Text] [Related]
13. Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.
Slosky LM; Thompson BJ; Sanchez-Covarrubias L; Zhang Y; Laracuente ML; Vanderah TW; Ronaldson PT; Davis TP
Mol Pharmacol; 2013 Nov; 84(5):774-86. PubMed ID: 24019224
[TBL] [Abstract][Full Text] [Related]
14. ABC transporter function and regulation at the blood-spinal cord barrier.
Campos CR; Schröter C; Wang X; Miller DS
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1559-66. PubMed ID: 22472606
[TBL] [Abstract][Full Text] [Related]
15. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.
Cartwright TA; Campos CR; Cannon RE; Miller DS
J Cereb Blood Flow Metab; 2013 Mar; 33(3):381-8. PubMed ID: 23168528
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
[TBL] [Abstract][Full Text] [Related]
17. Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier.
Cannon RE; Richards AC; Trexler AW; Juberg CT; Sinha B; Knudsen GA; Birnbaum LS
Environ Health Perspect; 2020 Mar; 128(3):37002. PubMed ID: 32212926
[TBL] [Abstract][Full Text] [Related]
18. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.
Hartz AM; Mahringer A; Miller DS; Bauer B
J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549
[TBL] [Abstract][Full Text] [Related]
19. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.
Mahringer A; Fricker G
Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
